Thyroid Clinical Trials in Beijing, Beijing Municipality
17 recruitingBeijing, Beijing Municipality, China
Showing 1–17 of 17 trials
Recruiting
Phase 1Phase 2
Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism
Hypoparathyroidism
Peking Union Medical College Hospital15 enrolled1 locationNCT07530705
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 3
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
Medullary Thyroid Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences150 enrolled1 locationNCT07383246
Recruiting
Phase 3
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.144 enrolled35 locationsNCT06860971
Recruiting
Phase 2
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited60 enrolled1 locationNCT06359847
Recruiting
Not Applicable
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Medullary Thyroid Carcinoma
Luo Yaping30 enrolled1 locationNCT07138716
Recruiting
Early Phase 1
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
MeningiomaNETsIodine-resistant Thyroid Cancer
Peking Union Medical College Hospital40 enrolled1 locationNCT06632860
Recruiting
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
Recurrent Thyroid Cancer
Chinese PLA General Hospital300 enrolled1 locationNCT06733766
Recruiting
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
Thyroid Nodule
Chinese PLA General Hospital600 enrolled2 locationsNCT06733753
Recruiting
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
Papillary Thyroid Cancer
Chinese PLA General Hospital3,000 enrolled1 locationNCT06733740
Recruiting
Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules
Thyroid Nodule
Ming-an Yu500 enrolled1 locationNCT06610604
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Not Applicable
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
Thyroid Eye Disease
Peking University Third Hospital50 enrolled1 locationNCT06359795
Recruiting
Phase 2
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
SurgeryThyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences140 enrolled1 locationNCT06087068
Recruiting
Phase 3
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
Thyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,199 enrolled1 locationNCT06082180
Recruiting
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.380 enrolled3 locationsNCT05994365
Recruiting
Phase 4
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Medullary Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.360 enrolled19 locationsNCT05830500